CKS Updates - November 2024
During November 2024 Clinical Knowledge Summaries were published or updated in the following areas.
- Bedwetting (enuresis)
- Blepharitis
- Functional neurological disorder
- Hirsutism
- Infectious mononucleosis (glandular fever)
- Psychosis and schizophrenia
- Raynaud's phenomenon
- Styes (hordeola)
- Trichomoniasis
The Functional neurological disorder topic is new. All of the topics have been reviewed and updated with minor structural and layout changes. The Infectious mononucleosis (glandular fever) topic has been renamed to reflect common terminology in the literature and the age cut-off below which to arrange Epstein-Barr virus (EBV) serology testing in children has been changed from 12 years to 4 years. The Raynaud's phenomenon topic has been updated such that the recommended dose of sustained-release nifedipine is in line with the consensus best practice pathway of the UK Scleroderma Study Group. The Trichomoniasis topic has been updated with the addition of information on the risk factors, prognosis and differential diagnosis and the diagnosis section includes information on sampling using nucleic acid amplification testing.
Action: Clinicians who see patients with any of these conditions may find the new and updated information useful when reviewing current clinical practice.
| « Follow on Bluesky or Mastodon | SMC Update - December 2024 » |
Leave a Comment